ED
Editas
EDIT·NASDAQCambridge MAFounded 2013340 employees
Small CapbiotechPublicGenetic MedicineOphthalmology
Platform: CRISPR
Market Cap
$0.5B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (EDIT)
Loading EDIT stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| EDI-3618 | EDI-3618 | NDA/BLA | 1 | FXIa | Endometrial CaADHD | ||
| Polazumab | EDI-8628 | Phase 2/3 | 1 | IL-13 | PompeEpilepsy |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (1)